Endocrinology Advisor1d
Novo Nordisk’s Wegovy, Ozempic No Longer in Short Supply, According to FDA
The Food and Drug Administration has determined that the shortage of Wegovy® (semaglutide) and Ozempic® (semaglutide) is resolved.
FiercePharma5d
Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod
Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
pharmaphorum2d
Novo sheds kidney drug licensed for $1.3bn a year ago
Novo Nordisk has abandoned a drug it licensed from KBP Biosciences last year in a deal valued at up to $1.3 billion after it missed the mark in a chronic kidney disease (CKD) trial. The Danish ...
pharmaphorum2d
Novo Nordisk grabs NASH drug from Ventus in $703m deal
Along with NASH, Novo Nordisk is also planning to investigate the drug's activity in chronic kidney disease and cardiometabolic conditions. She added that VENT-01 has the potential to offer "best ...
England subsidizes drugs like Ozempic for weight loss. Could Australia follow?
People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...
The GLP-1 Revolution — How Private Equity Investors Are Capitalizing
The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...
Knowridge1d
Pay attention to 4 health factors to prevent new heart syndrome
About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...
verywellhealth5h
5 Stages of Chronic Kidney Disease (CKD) From First Symptoms to Kidney Failure
The five stages of chronic kidney disease (CKD) indicate how well the kidneys are working, ranging from stage 1 (mild kidney ...